sr 140333 has been researched along with enalapril in 1 studies
| Studies (sr 140333) | Trials (sr 140333) | Recent Studies (post-2010) (sr 140333) | Studies (enalapril) | Trials (enalapril) | Recent Studies (post-2010) (enalapril) |
|---|---|---|---|---|---|
| 236 | 0 | 12 | 6,311 | 1,924 | 859 |
| Protein | Taxonomy | sr 140333 (IC50) | enalapril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.3536 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 2.7083 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 1.2 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.14 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunnett, NW; Emanueli, C; Figini, M; Geppetti, P; Grady, EF; Madeddu, P; Parisi, D; Regoli, D | 1 |
1 other study(ies) available for sr 140333 and enalapril
| Article | Year |
|---|---|
Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Coloring Agents; Data Interpretation, Statistical; Enalapril; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Indicators and Reagents; Indoles; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Organometallic Compounds; Piperidines; Quinuclidines; Substance P; Time Factors | 1998 |